Prof. Dr. Gunhild von Amsberg holds a professorship in Uro-Oncology at the Department of Hematology and Oncology, Martini-Klinik, and the Center of Oncology at the University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf (UKE), Germany. 

Her clinical and scientific work is dedicated to systemic treatment strategies for advanced prostate cancer, urothelial carcinoma, and renal cell carcinoma. She integrates innovative treatment approaches—such as clinical trials and precision oncology—into routine care. Her translational and basic research aims to develop novel therapeutic strategies to overcome resistance to currently available standard treatments in advanced prostate cancer. 

Prof. von Amsberg is a member of the German S3 Guideline Committees for Prostate, Penile, and Urothelial Carcinoma, and serves on the Independent Data Monitoring Committee of the Swiss Group for Clinical Cancer Research (SAKK). She has received multiple academic honors, including honorary membership of the German Society of Urology (DGU). She is the author of numerous peer-reviewed publications and book chapters and regularly acts as a reviewer for national and international scientific journals. 

 

Prof. Gunhild von Amsberg has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies: